Leap Therapeutics (LPTX) Investor Presentation - Slideshow
Leap Therapeutics(LPTX)2019-04-10 18:14.. . leaptherapeutics LEAP THERAPEUT Patient Number / Patienten Sponsor Trial Code / Drug name: DKN-01 for inte DKN-01 zur intravenösen Potency / Dosisstärke: 200 Sponsor/CRO: Universität Langenbeckstr. 1 5E4 . Company Overview| April 2019 Leap Therapeutics | | Forward Looking Statements This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regardi ...